Hepatoportal vein GLP-1 receptors contribute to the incretin effect of the peptide

被引：0
|
作者：
Stettler, KM
Edgerton, DS
Rodewald, T
Neal, D
Scott, MF
Snead, W
Cherrington, AD
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A364 / A364
页数：1
相关论文
共 50 条
  • [31] The physiological role of GLP-1 in human:: Incretin, ileal brake or more?
    Schirra, J
    Göke, B
    REGULATORY PEPTIDES, 2005, 128 (02) : 109 - 115
  • [32] GLP-1 Receptor as a Biomarker for Incretin Function in Type 2 Diabetes
    Rajan, Sindhu
    Ancsin, John B.
    Mathew, Elizabeth
    Janardanan, Jyothi
    Philipson, Louis
    DIABETES, 2013, 62 : A473 - A473
  • [33] Glucagon-like peptide-1 (GLP-1), a gut incretin, protects the myocardium against ischemic/reperfusion injury through the myocardial GLP-1 receptor and activation of prosurvival pathways
    Bose, AK
    Mocanu, MM
    Inst, H
    Brand, CL
    Carr, RD
    Yellon, DM
    CIRCULATION, 2004, 110 (17) : 68 - 68
  • [34] Brain Endothelial Cells Take Up Glucagon-like Peptide 1 (GLP-1) via GLP-1 Receptors and Protein Kinase A (PKA) Signaling
    Fu, Zhuo
    Gray, Sarah M.
    Aylor, Kevin
    Barrett, Eugene J.
    Liu, Zhenqi
    DIABETES, 2016, 65 : A485 - A485
  • [35] GIP and GLP-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice
    Hansotia, T
    Drucker, DJ
    REGULATORY PEPTIDES, 2005, 128 (02) : 125 - 134
  • [36] Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: Cholinergic control of GLP-1 secretion via muscarinic receptors
    Balks, HJ
    Holst, JJ
    vonzurMuhlen, A
    Brabant, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03): : 786 - 790
  • [37] New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)
    Yu, Zhiwen
    Jin, Tianru
    CELLULAR SIGNALLING, 2010, 22 (01) : 1 - 8
  • [38] Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results
    Martin Gotthardt
    Marc Fischer
    Inga Naeher
    Josefin B. Holz
    Hartmut Jungclas
    Hans-Walter Fritsch
    Martin Béhé
    Burkhard Göke
    Klaus Joseph
    Thomas M. Behr
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 597 - 606
  • [39] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    MOLECULAR METABOLISM, 2019, 30 : 72 - 130
  • [40] Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas:: initial experimental results
    Gotthardt, M
    Fischer, M
    Naeher, I
    Holz, JB
    Jungclas, H
    Fritsch, HW
    Béhé, M
    Göke, B
    Joseph, K
    Behr, TM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (05) : 597 - 606
12345